Biology Reference
In-Depth Information
Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MBA. 1994. Virus speci®c CD8
cytotoxic
T lymphocyte activity associated with control of viremia in primary human immunode®ciency
virus type 1 infection. J Virol 68: 6103±6110.
Borthwick NJ, Bo®ll M, Gombert WM. 1994. Lymphocyte activation in HIV-1 infection II. Func-
tional defects of CD28
ÿ
T cells. AIDS 8: 431±441.
Boucher N, Defeu-Duchesne T, Vicaut E, Farge D, E¨ros RB, Schachter F. 1998. CD28 expression
in T cell aging and human longevity. Exp Gerontol 33: 267±282.
Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. 1994. Expression of
costimulatory molecule CD28 on T cells in human immunode®ciency virus type 1 infection:
functional and clinical correlations. J Infect Dis 169: 730±738.
Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, Greenberg PD, Riddell
SR. 1999. In vivo migration and function of transferred HIV-1-speci®c cytotoxic T cells [see
comments]. Nat Med 5: 34±41.
Bryant JE, Hutchings KG, Moyzis RK, Gri½th JK. 1997. Measurement of telomeric DNA content
in human tissues. Biotechniques 23: 276±284.
Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ,
Rickinson AB. 1998. Direct visualization of antigen-speci®c CD8
T cells during the primary
immune response to Epstein-Barr virus in vivo. J Exp Med 187: 1395±1402.
Campisi J, Dimri G, Hara E. 1996. Control of replicative senescence. In: Schneider JRE (ed).
Handbook of the Biology of Aging. San Diego, CA, Academic Press, pp 121±140.
Cao Y, Qin L, Zhang L, Safrit J, Ho D. 1995. Virologic and immunologic characterization of long
term survivors of human immunode®ceiency virus type 1 infection. N Engl J Med 332: 201±208.
Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, Schneider V, Saimot AG, Damond F,
Simon F, Debrae P, Autran B, Girard PM. 1999. T cell changes after combined nucleoside
analogue therapy in HIV primary infection. AIDS 13: 1077±1081.
Carmichael A, Jin X, Sissons P, Borysiewicz L. 1993. Quantitative analysis of the human im-
munode®ciency virus type 1 (HIV-1)-speci®c cytotoxic T lymphocyte (CTL) response at di¨er-
ent stages of HIV-1 infection: di¨erential CTL responses to HIV-1 and Epstein-Barr virus in late
disease. J Exp Med 177: 249±256.
Caruso A, Licenziati S, Canaris AD, Cantalamessa A, Fiorentini S, Ausenda S, Ricotta D, Dima F,
Malacarne F, Balsari A, Turano A. 1998. Contribution of CD4
, CD8
CD28
, and
CD8
CD28
ÿ
T cells to CD3
lymphocyte homeostasis during the natural course of HIV-1 in-
fection. J Clin Invest 101: 137±144.
Choremi-Papadopoulou H, Panagiotou N, Samouilidou E, Kontopidou F, Viglis V, Antoniadou A,
Kosmidis J, Kordossis T. 2000. CD28 costimulation and CD28 expression in T lymphocyte
subsets in HIV-1 infection with and without progression to AIDS. Clin Exp Immunol 119: 499±
506.
Cossarizza A, Ortolani C, Mussini C, Borghi V, Guaraldi G, Mongiardo N, Bellesia E, France-
schini MG, De Rienzo B, Franceschi C. 1995. Massive activation of immune cells with an
intact T cell repertoire in acute human immunode®ciency virus syndrome. J Infect Dis 172: 105±
112.
Counter CM, Hirte HW, Bacchetti S, Harley CB. 1994. Telomerase activity in human ovarian
carcinoma. Proc Natl Acad Sci USA 91: 2900±2904.
Dalod M, Sinet M, Deschemin JC, Fiorentino S, Venet A, Guillet JG. 1999. Altered ex vivo bal-
ance between CD28
and CD28
ÿ
cells within HIV-speci®c CD8
T cells of HIV-seropositive
patients. Eur J Immunol 29: 38±44.
E¨ros RB. 1998. Replicative senescence in the immune system: impact of the Hay¯ick limit on
T-cell function in the elderly. Am J Hum Genet 62: 1003±1007.
E¨ros RB, Pawelec G. 1997. Replicative senescence of T lymphocytes: does the Hay¯ick limit lead
to immune exhaustion? Immunol Today 18: 450±454.